% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • hippocampus48 hippocampus48 Feb 18, 2013 10:03 AM Flag

    AF is right again!

    From the last 20 or so posts ( from knowledgable postings) it seems that IMUC has used a very favorable 14.5 month OS in their previous comparisons. We should be using a more realistic 17-18 month comparison. This seems very puzzling since at the last presentation we were led to expect a 32 death threshold this 1st Quarter which would mean little or no benefit??????? Even a 2nd QTR 32 threshold would mean that a much larger P3 taking years would need to be initiated fro possible approval. May be this is why the stock is still a $2 stock?

0.2375+0.0185(+8.45%)Jun 28 4:01 PMEDT